AR042404A2 - Compuestos derivados de anilina - Google Patents

Compuestos derivados de anilina

Info

Publication number
AR042404A2
AR042404A2 ARP030100070A ARP030100070A AR042404A2 AR 042404 A2 AR042404 A2 AR 042404A2 AR P030100070 A ARP030100070 A AR P030100070A AR P030100070 A ARP030100070 A AR P030100070A AR 042404 A2 AR042404 A2 AR 042404A2
Authority
AR
Argentina
Prior art keywords
compound
formula
fluorine
chlorine
ethyl
Prior art date
Application number
ARP030100070A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR042404A2 publication Critical patent/AR042404A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/54—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
    • C07C211/56—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Abstract

Un compuesto derivado de anilina seleccionado a partir de: a) un compuesto de la fórmula (1); b) un compuesto de la fórmula (2); un compuesto de la fórmula (3); d) un compuesto de la fórmula (4); e) un compuesto de la fórmula (5); f) un compuesto de la fórmula (6); un compuesto de la fórmula (7), en donde R es metilo o etilo; R1 es cloro o flúor; R2 es hidrógeno o flúor; R3 es hidrógeno, flúor, cloro, metilo, etilo, metoxilo, etoxilo, o hidroxilo; R4 es hidrógeno o flúor; y R5 es cloro, flúor, trifluorometilo, o metilo, con la condición de que R1, R2, R3, y R4 no sean todos flúor cuando R sea etilo y R3 sea H. Los compuestos de la presente, las sales farmacéuticamente aceptables de los mismos, y los éteres de profármaco farmacéuticamente aceptables de los mismos, son intermediarios para la producción de ácidos 2-fenilamino-5-alquilfenilacéticos.
ARP030100070A 1999-09-27 2003-01-10 Compuestos derivados de anilina AR042404A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9922830.6A GB9922830D0 (en) 1999-09-27 1999-09-27 Processes

Publications (1)

Publication Number Publication Date
AR042404A2 true AR042404A2 (es) 2005-06-22

Family

ID=10861676

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP000105014A AR031529A1 (es) 1999-09-27 2000-09-25 Proceso para la produccion de derivados del acido 5-alquilfenilacetico
ARP030100070A AR042404A2 (es) 1999-09-27 2003-01-10 Compuestos derivados de anilina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP000105014A AR031529A1 (es) 1999-09-27 2000-09-25 Proceso para la produccion de derivados del acido 5-alquilfenilacetico

Country Status (34)

Country Link
US (2) US20080249318A1 (es)
EP (2) EP2275403A1 (es)
JP (1) JP2003510303A (es)
KR (1) KR100745341B1 (es)
CN (1) CN100412053C (es)
AR (2) AR031529A1 (es)
AT (1) ATE447547T1 (es)
AU (1) AU775416B2 (es)
BR (1) BR0014314A (es)
CA (1) CA2379553C (es)
CO (1) CO5210865A1 (es)
CY (1) CY1110539T1 (es)
CZ (1) CZ20021027A3 (es)
DE (1) DE60043261D1 (es)
DK (1) DK1216226T3 (es)
EC (2) ECSP003680A (es)
ES (1) ES2338209T3 (es)
GB (1) GB9922830D0 (es)
HK (1) HK1047739A1 (es)
HU (1) HUP0202728A3 (es)
IL (2) IL148330A0 (es)
MY (1) MY125201A (es)
NO (1) NO327912B1 (es)
NZ (1) NZ517461A (es)
PE (1) PE20010644A1 (es)
PL (1) PL207777B1 (es)
PT (1) PT1216226E (es)
RU (1) RU2273628C2 (es)
SI (1) SI1216226T1 (es)
SK (1) SK287241B6 (es)
TR (1) TR200200745T2 (es)
TW (1) TWI270540B (es)
WO (1) WO2001023346A2 (es)
ZA (1) ZA200202367B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209257D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds
AR042206A1 (es) 2002-11-26 2005-06-15 Novartis Ag Acidos fenilaceticos y derivados
US7161026B1 (en) 2005-07-08 2007-01-09 Property Development Corporation International, Ltd, Inc. Method of preparation of methyl-benzyl-ketone
AR061623A1 (es) 2006-06-26 2008-09-10 Novartis Ag Derivados de acido fenilacetico
US8227451B2 (en) 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
CN102311355B (zh) * 2011-09-26 2014-02-05 扬州天和药业有限公司 罗本考昔的一种制备方法
CN107721901A (zh) * 2017-11-12 2018-02-23 刘磊 一种2‑[2‑(2,3,5,6‑四氟苯胺基)苯基]乙酸的制备方法
EP3830072A1 (en) 2018-07-27 2021-06-09 KRKA, d.d., Novo mesto A process for the preparation of polymorphic form of robenacoxib
WO2020027258A1 (ja) * 2018-08-03 2020-02-06 日産化学株式会社 フッ化芳香族第二級アミン化合物の製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
IT1097265B (it) 1978-06-23 1985-08-31 Acraf Nouva sintesi di un acido fenilacetico
JPS5677246A (en) * 1980-11-27 1981-06-25 Nissan Chem Ind Ltd Production of substituted phenylacetic acid
DE3404401C2 (de) 1984-02-08 1994-02-10 Hoechst Ag Verwendung von Aryloxy-Verbindungen als Antidots
FR2578836B1 (fr) 1985-03-12 1987-04-17 Rhone Poulenc Spec Chim Procede de chloration selective de composes phenoliques
ES2065928T3 (es) * 1989-01-27 1995-03-01 Heumann Pharma Gmbh & Co Procedimiento para la fabricacion de derivados de acido 2,6-diclorodifenilaminacetico.
IT1248032B (it) * 1991-06-11 1995-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della n- (2,6-diclorofenil) -n-fenil-n-(cloroacetil)-ammina.
CN1091420A (zh) * 1993-02-25 1994-08-31 永信药品工业股份有限公司 二苯胺衍生物的制备方法
JPH0789951A (ja) 1993-06-03 1995-04-04 Sterling Winthrop Inc インターロイキン−１β転換酵素阻害剤
US5475139A (en) 1993-10-22 1995-12-12 Yung Shin Pharm. Ind. Co., Ltd. Method for the preparation of substituted derivatives of diphenyl amine
CA2189036A1 (en) 1994-04-29 1995-11-09 Roland E. Dolle Halomethyl amides as il-1.beta. protease inhibitors
US5576460A (en) 1994-07-27 1996-11-19 Massachusetts Institute Of Technology Preparation of arylamines
JPH0977664A (ja) * 1995-09-13 1997-03-25 Yakult Honsha Co Ltd シクロオキシゲナーゼ−２特異的阻害剤及び抗炎症剤
US6355680B1 (en) 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
US6034266A (en) 1996-03-11 2000-03-07 Fundacao Oswaldo Cruz-Fiocruz Gem-difluoro derivative of phenylacetamide and phenylacetic acid and their pharmaceutical uses
BR9600975A (pt) * 1996-03-11 1997-12-30 Fundacao Oswaldo Cruz Derivados do ácido gem-difluorfenilacético e de gem-difluorfenilacetamida processo de sua preparação e suas aplicações farmacêuticas
CA2208900C (en) 1996-07-18 2006-08-01 Lonza Ag Process for preparing 2-pyrimidinecarboxylates
US5817877A (en) 1996-09-23 1998-10-06 Yale University Metal-catalyzed amination of organic sulfonates to organic amines
CO4960662A1 (es) 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados

Also Published As

Publication number Publication date
AR031529A1 (es) 2003-09-24
PT1216226E (pt) 2009-12-17
SI1216226T1 (sl) 2010-03-31
CA2379553A1 (en) 2001-04-05
DK1216226T3 (da) 2010-02-01
SK4142002A3 (en) 2002-08-06
MY125201A (en) 2006-07-31
SK287241B6 (sk) 2010-04-07
AU7906700A (en) 2001-04-30
HUP0202728A3 (en) 2003-11-28
WO2001023346A2 (en) 2001-04-05
TR200200745T2 (tr) 2002-06-21
HK1047739A1 (en) 2003-03-07
HUP0202728A2 (hu) 2002-12-28
AU775416B2 (en) 2004-07-29
KR100745341B1 (ko) 2007-08-02
CN100412053C (zh) 2008-08-20
NO20021368D0 (no) 2002-03-19
ECSP003680A (es) 2002-04-23
PE20010644A1 (es) 2001-06-15
US20080249318A1 (en) 2008-10-09
RU2273628C2 (ru) 2006-04-10
US7906677B2 (en) 2011-03-15
IL148330A0 (en) 2002-09-12
KR20020030289A (ko) 2002-04-24
ATE447547T1 (de) 2009-11-15
CN1377337A (zh) 2002-10-30
EP1216226B1 (en) 2009-11-04
EP2275403A1 (en) 2011-01-19
CA2379553C (en) 2010-09-21
NO20021368L (no) 2002-05-27
WO2001023346A3 (en) 2002-01-10
CY1110539T1 (el) 2015-04-29
CO5210865A1 (es) 2002-10-30
US20090275758A1 (en) 2009-11-05
DE60043261D1 (de) 2009-12-17
NZ517461A (en) 2003-10-31
GB9922830D0 (en) 1999-11-24
PL207777B1 (pl) 2011-01-31
JP2003510303A (ja) 2003-03-18
ES2338209T3 (es) 2010-05-05
NO327912B1 (no) 2009-10-19
IL148330A (en) 2007-02-11
CZ20021027A3 (cs) 2002-07-17
BR0014314A (pt) 2002-11-12
ZA200202367B (en) 2003-02-26
TWI270540B (en) 2007-01-11
EP1216226A2 (en) 2002-06-26
PL365994A1 (en) 2005-01-24
ECSP093680A (es) 2009-02-27

Similar Documents

Publication Publication Date Title
WO2001077107A8 (en) Oxazole derivatives and their uses as tyrosine kinase inhibitors
CA2298033A1 (en) Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
CO5231161A1 (es) 4-aminopicolinatos y su uso como herbicidas
ES2192397T3 (es) Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico.
CU23006A3 (es) Nuevos ésteres derivados de compuestos fenil-ciclonuevos ésteres derivados de compuestos fenil-ciclohexil sustituidos hexil sustituidos
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
AR042404A2 (es) Compuestos derivados de anilina
AU7927591A (en) Substituted aminoalkylbiphenyl derivatives
ES2191985T3 (es) S-oxido de tetrahidrotiopirano feniloxazolidinonas.
RS50229B (sr) Analozi vitamina d3
WO2002028844A1 (fr) Dérivés thiazole ou oxazole
IE800918L (en) Phenylethylamine derivatives
EP1270569A4 (en) SUBSTITUTED TRYPTOPHAN DERIVATIVES
MX25858A (es) 3-[1-tiazolidinilbutil-4-piperazinil]-1h-indazolesun procedimiento para su preparacion y su uso comomedicamentos.
CA2334568A1 (en) Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems
IS2084B (is) Aðferð við að framleiða útskipt imídasópýridínefnasamband
MXPA04003086A (es) Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
ES2190781T3 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
DE69810622D1 (de) Naphthothiazolon-derivate die auf den dopaminergen rezeptor d 3 wirken
AP9901635A0 (en) Anti-convulsant isoquinolyl-benzamide derivatives.
EP1650199A4 (en) SULPHONAMIDE DERIVATIVE WITH ISOXAZOL RING
AU6675696A (en) A novel asymmetric synthesis of r and s warfarin and its analogs
ATE522499T1 (de) Verfahren zur herstellung von tamsulosin und seinen derivaten
HUP0001545A2 (hu) Karbonsavészterszármazékok, előállításuk és alkalmazásuk herbicid hatású piridazin-3-on-származékok előállítására
DK0675880T3 (da) Quinolondisulfider som mellemprodukter

Legal Events

Date Code Title Description
FB Suspension of granting procedure